Gerresheimer AG (ETR:GXI) has earned an average rating of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is €69.85 ($86.24).
A number of research analysts have commented on the company. Berenberg Bank set a €78.00 ($96.30) price objective on Gerresheimer and gave the company a “buy” rating in a report on Friday, March 9th. Deutsche Bank set a €66.00 ($81.48) target price on Gerresheimer and gave the stock a “neutral” rating in a report on Monday, January 22nd. JPMorgan Chase & Co. set a €87.70 ($108.27) target price on Gerresheimer and gave the stock a “buy” rating in a report on Thursday, January 4th. equinet set a €75.00 ($92.59) target price on Gerresheimer and gave the stock a “neutral” rating in a report on Friday, January 19th. Finally, Hauck & Aufhaeuser set a €55.00 ($67.90) target price on Gerresheimer and gave the stock a “sell” rating in a report on Thursday, January 18th.
Gerresheimer (GXI) opened at €67.35 ($83.15) on Wednesday. Gerresheimer has a 1-year low of €59.97 ($74.04) and a 1-year high of €78.25 ($96.60). The company has a market capitalization of $2,080.00 and a price-to-earnings ratio of 20.98.
WARNING: “Gerresheimer AG (GXI) Receives Consensus Recommendation of “Hold” from Analysts” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://sportsperspectives.com/2018/03/14/gerresheimer-ag-gxi-receives-consensus-recommendation-of-hold-from-analysts.html.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.